Global Genetic Disorders Drug Market Insights and Forecast to 2028

Report ID: 1547982 | Published Date: Jan 2025 | No. of Page: 97 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Genetic Disorders Drug Product Introduction
    1.2 Market by Type
        1.2.1 Global Genetic Disorders Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Cystic Fibrosis (CF)
        1.2.3 Duchenne Muscular Dystrophy (DMD)
        1.2.4 Lysosomal Storage Disease (LSD)
        1.2.5 Paroxysmal Nocturnal Hemoglobinuria (PNH)
    1.3 Market by Application
        1.3.1 Global Genetic Disorders Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Clinic
        1.3.3 Hospital
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Genetic Disorders Drug Sales Estimates and Forecasts 2017-2028
    2.2 Global Genetic Disorders Drug Revenue Estimates and Forecasts 2017-2028
    2.3 Global Genetic Disorders Drug Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Genetic Disorders Drug Sales by Region
        2.4.1 Global Genetic Disorders Drug Sales by Region (2017-2022)
        2.4.2 Global Sales Genetic Disorders Drug by Region (2023-2028)
    2.5 Global Genetic Disorders Drug Revenue by Region
        2.5.1 Global Genetic Disorders Drug Revenue by Region (2017-2022)
        2.5.2 Global Genetic Disorders Drug Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Genetic Disorders Drug Sales by Manufacturers
        3.1.1 Global Top Genetic Disorders Drug Manufacturers by Sales (2017-2022)
        3.1.2 Global Genetic Disorders Drug Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Genetic Disorders Drug in 2021
    3.2 Global Genetic Disorders Drug Revenue by Manufacturers
        3.2.1 Global Genetic Disorders Drug Revenue by Manufacturers (2017-2022)
        3.2.2 Global Genetic Disorders Drug Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Genetic Disorders Drug Revenue in 2021
    3.3 Global Genetic Disorders Drug Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Genetic Disorders Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Genetic Disorders Drug Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Genetic Disorders Drug Sales by Type
        4.1.1 Global Genetic Disorders Drug Historical Sales by Type (2017-2022)
        4.1.2 Global Genetic Disorders Drug Forecasted Sales by Type (2023-2028)
        4.1.3 Global Genetic Disorders Drug Sales Market Share by Type (2017-2028)
    4.2 Global Genetic Disorders Drug Revenue by Type
        4.2.1 Global Genetic Disorders Drug Historical Revenue by Type (2017-2022)
        4.2.2 Global Genetic Disorders Drug Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Genetic Disorders Drug Revenue Market Share by Type (2017-2028)
    4.3 Global Genetic Disorders Drug Price by Type
        4.3.1 Global Genetic Disorders Drug Price by Type (2017-2022)
        4.3.2 Global Genetic Disorders Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Genetic Disorders Drug Sales by Application
        5.1.1 Global Genetic Disorders Drug Historical Sales by Application (2017-2022)
        5.1.2 Global Genetic Disorders Drug Forecasted Sales by Application (2023-2028)
        5.1.3 Global Genetic Disorders Drug Sales Market Share by Application (2017-2028)
    5.2 Global Genetic Disorders Drug Revenue by Application
        5.2.1 Global Genetic Disorders Drug Historical Revenue by Application (2017-2022)
        5.2.2 Global Genetic Disorders Drug Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Genetic Disorders Drug Revenue Market Share by Application (2017-2028)
    5.3 Global Genetic Disorders Drug Price by Application
        5.3.1 Global Genetic Disorders Drug Price by Application (2017-2022)
        5.3.2 Global Genetic Disorders Drug Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Genetic Disorders Drug Market Size by Type
        6.1.1 North America Genetic Disorders Drug Sales by Type (2017-2028)
        6.1.2 North America Genetic Disorders Drug Revenue by Type (2017-2028)
    6.2 North America Genetic Disorders Drug Market Size by Application
        6.2.1 North America Genetic Disorders Drug Sales by Application (2017-2028)
        6.2.2 North America Genetic Disorders Drug Revenue by Application (2017-2028)
    6.3 North America Genetic Disorders Drug Market Size by Country
        6.3.1 North America Genetic Disorders Drug Sales by Country (2017-2028)
        6.3.2 North America Genetic Disorders Drug Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Genetic Disorders Drug Market Size by Type
        7.1.1 Europe Genetic Disorders Drug Sales by Type (2017-2028)
        7.1.2 Europe Genetic Disorders Drug Revenue by Type (2017-2028)
    7.2 Europe Genetic Disorders Drug Market Size by Application
        7.2.1 Europe Genetic Disorders Drug Sales by Application (2017-2028)
        7.2.2 Europe Genetic Disorders Drug Revenue by Application (2017-2028)
    7.3 Europe Genetic Disorders Drug Market Size by Country
        7.3.1 Europe Genetic Disorders Drug Sales by Country (2017-2028)
        7.3.2 Europe Genetic Disorders Drug Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Genetic Disorders Drug Market Size by Type
        8.1.1 Asia Pacific Genetic Disorders Drug Sales by Type (2017-2028)
        8.1.2 Asia Pacific Genetic Disorders Drug Revenue by Type (2017-2028)
    8.2 Asia Pacific Genetic Disorders Drug Market Size by Application
        8.2.1 Asia Pacific Genetic Disorders Drug Sales by Application (2017-2028)
        8.2.2 Asia Pacific Genetic Disorders Drug Revenue by Application (2017-2028)
    8.3 Asia Pacific Genetic Disorders Drug Market Size by Region
        8.3.1 Asia Pacific Genetic Disorders Drug Sales by Region (2017-2028)
        8.3.2 Asia Pacific Genetic Disorders Drug Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Genetic Disorders Drug Market Size by Type
        9.1.1 Latin America Genetic Disorders Drug Sales by Type (2017-2028)
        9.1.2 Latin America Genetic Disorders Drug Revenue by Type (2017-2028)
    9.2 Latin America Genetic Disorders Drug Market Size by Application
        9.2.1 Latin America Genetic Disorders Drug Sales by Application (2017-2028)
        9.2.2 Latin America Genetic Disorders Drug Revenue by Application (2017-2028)
    9.3 Latin America Genetic Disorders Drug Market Size by Country
        9.3.1 Latin America Genetic Disorders Drug Sales by Country (2017-2028)
        9.3.2 Latin America Genetic Disorders Drug Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Genetic Disorders Drug Market Size by Type
        10.1.1 Middle East and Africa Genetic Disorders Drug Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Genetic Disorders Drug Revenue by Type (2017-2028)
    10.2 Middle East and Africa Genetic Disorders Drug Market Size by Application
        10.2.1 Middle East and Africa Genetic Disorders Drug Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Genetic Disorders Drug Revenue by Application (2017-2028)
    10.3 Middle East and Africa Genetic Disorders Drug Market Size by Country
        10.3.1 Middle East and Africa Genetic Disorders Drug Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Genetic Disorders Drug Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Sanofi
        11.1.1 Sanofi Corporation Information
        11.1.2 Sanofi Overview
        11.1.3 Sanofi Genetic Disorders Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Sanofi Genetic Disorders Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Sanofi Recent Developments
    11.2 Vertex
        11.2.1 Vertex Corporation Information
        11.2.2 Vertex Overview
        11.2.3 Vertex Genetic Disorders Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Vertex Genetic Disorders Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Vertex Recent Developments
    11.3 Takeda
        11.3.1 Takeda Corporation Information
        11.3.2 Takeda Overview
        11.3.3 Takeda Genetic Disorders Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Takeda Genetic Disorders Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Takeda Recent Developments
    11.4 Amgen
        11.4.1 Amgen Corporation Information
        11.4.2 Amgen Overview
        11.4.3 Amgen Genetic Disorders Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Amgen Genetic Disorders Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Amgen Recent Developments
    11.5 GW Pharmaceuticals
        11.5.1 GW Pharmaceuticals Corporation Information
        11.5.2 GW Pharmaceuticals Overview
        11.5.3 GW Pharmaceuticals Genetic Disorders Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 GW Pharmaceuticals Genetic Disorders Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 GW Pharmaceuticals Recent Developments
    11.6 Pfizer
        11.6.1 Pfizer Corporation Information
        11.6.2 Pfizer Overview
        11.6.3 Pfizer Genetic Disorders Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Pfizer Genetic Disorders Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Pfizer Recent Developments
    11.7 BioMarin
        11.7.1 BioMarin Corporation Information
        11.7.2 BioMarin Overview
        11.7.3 BioMarin Genetic Disorders Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 BioMarin Genetic Disorders Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 BioMarin Recent Developments
    11.8 Sarepta
        11.8.1 Sarepta Corporation Information
        11.8.2 Sarepta Overview
        11.8.3 Sarepta Genetic Disorders Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Sarepta Genetic Disorders Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Sarepta Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Genetic Disorders Drug Industry Chain Analysis
    12.2 Genetic Disorders Drug Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Genetic Disorders Drug Production Mode & Process
    12.4 Genetic Disorders Drug Sales and Marketing
        12.4.1 Genetic Disorders Drug Sales Channels
        12.4.2 Genetic Disorders Drug Distributors
    12.5 Genetic Disorders Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Genetic Disorders Drug Industry Trends
    13.2 Genetic Disorders Drug Market Drivers
    13.3 Genetic Disorders Drug Market Challenges
    13.4 Genetic Disorders Drug Market Restraints
14 Key Findings in The Global Genetic Disorders Drug Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Genetic Disorders Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Cystic Fibrosis (CF)
    Table 3. Major Manufacturers of Duchenne Muscular Dystrophy (DMD)
    Table 4. Major Manufacturers of Lysosomal Storage Disease (LSD)
    Table 5. Major Manufacturers of Paroxysmal Nocturnal Hemoglobinuria (PNH)
    Table 6. Global Genetic Disorders Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Genetic Disorders Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Genetic Disorders Drug Sales by Region (2017-2022) & (K Doses)
    Table 9. Global Genetic Disorders Drug Sales Market Share by Region (2017-2022)
    Table 10. Global Genetic Disorders Drug Sales by Region (2023-2028) & (K Doses)
    Table 11. Global Genetic Disorders Drug Sales Market Share by Region (2023-2028)
    Table 12. Global Genetic Disorders Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Genetic Disorders Drug Revenue Market Share by Region (2017-2022)
    Table 14. Global Genetic Disorders Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Genetic Disorders Drug Revenue Market Share by Region (2023-2028)
    Table 16. Global Genetic Disorders Drug Sales by Manufacturers (2017-2022) & (K Doses)
    Table 17. Global Genetic Disorders Drug Sales Share by Manufacturers (2017-2022)
    Table 18. Global Genetic Disorders Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Genetic Disorders Drug Revenue Share by Manufacturers (2017-2022)
    Table 20. Genetic Disorders Drug Price by Manufacturers (2017-2022) &(USD/Dose)
    Table 21. Global Genetic Disorders Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Genetic Disorders Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetic Disorders Drug as of 2021)
    Table 23. Genetic Disorders Drug Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Genetic Disorders Drug Product Offered
    Table 25. Date of Manufacturers Enter into Genetic Disorders Drug Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Genetic Disorders Drug Sales by Type (2017-2022) & (K Doses)
    Table 28. Global Genetic Disorders Drug Sales by Type (2023-2028) & (K Doses)
    Table 29. Global Genetic Disorders Drug Sales Share by Type (2017-2022)
    Table 30. Global Genetic Disorders Drug Sales Share by Type (2023-2028)
    Table 31. Global Genetic Disorders Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Genetic Disorders Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Genetic Disorders Drug Revenue Share by Type (2017-2022)
    Table 34. Global Genetic Disorders Drug Revenue Share by Type (2023-2028)
    Table 35. Genetic Disorders Drug Price by Type (2017-2022) & (USD/Dose)
    Table 36. Global Genetic Disorders Drug Price Forecast by Type (2023-2028) & (USD/Dose)
    Table 37. Global Genetic Disorders Drug Sales by Application (2017-2022) & (K Doses)
    Table 38. Global Genetic Disorders Drug Sales by Application (2023-2028) & (K Doses)
    Table 39. Global Genetic Disorders Drug Sales Share by Application (2017-2022)
    Table 40. Global Genetic Disorders Drug Sales Share by Application (2023-2028)
    Table 41. Global Genetic Disorders Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Genetic Disorders Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Genetic Disorders Drug Revenue Share by Application (2017-2022)
    Table 44. Global Genetic Disorders Drug Revenue Share by Application (2023-2028)
    Table 45. Genetic Disorders Drug Price by Application (2017-2022) & (USD/Dose)
    Table 46. Global Genetic Disorders Drug Price Forecast by Application (2023-2028) & (USD/Dose)
    Table 47. North America Genetic Disorders Drug Sales by Type (2017-2022) & (K Doses)
    Table 48. North America Genetic Disorders Drug Sales by Type (2023-2028) & (K Doses)
    Table 49. North America Genetic Disorders Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Genetic Disorders Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Genetic Disorders Drug Sales by Application (2017-2022) & (K Doses)
    Table 52. North America Genetic Disorders Drug Sales by Application (2023-2028) & (K Doses)
    Table 53. North America Genetic Disorders Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Genetic Disorders Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Genetic Disorders Drug Sales by Country (2017-2022) & (K Doses)
    Table 56. North America Genetic Disorders Drug Sales by Country (2023-2028) & (K Doses)
    Table 57. North America Genetic Disorders Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Genetic Disorders Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Genetic Disorders Drug Sales by Type (2017-2022) & (K Doses)
    Table 60. Europe Genetic Disorders Drug Sales by Type (2023-2028) & (K Doses)
    Table 61. Europe Genetic Disorders Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Genetic Disorders Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Genetic Disorders Drug Sales by Application (2017-2022) & (K Doses)
    Table 64. Europe Genetic Disorders Drug Sales by Application (2023-2028) & (K Doses)
    Table 65. Europe Genetic Disorders Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Genetic Disorders Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Genetic Disorders Drug Sales by Country (2017-2022) & (K Doses)
    Table 68. Europe Genetic Disorders Drug Sales by Country (2023-2028) & (K Doses)
    Table 69. Europe Genetic Disorders Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Genetic Disorders Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Genetic Disorders Drug Sales by Type (2017-2022) & (K Doses)
    Table 72. Asia Pacific Genetic Disorders Drug Sales by Type (2023-2028) & (K Doses)
    Table 73. Asia Pacific Genetic Disorders Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Genetic Disorders Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Genetic Disorders Drug Sales by Application (2017-2022) & (K Doses)
    Table 76. Asia Pacific Genetic Disorders Drug Sales by Application (2023-2028) & (K Doses)
    Table 77. Asia Pacific Genetic Disorders Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Genetic Disorders Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Genetic Disorders Drug Sales by Region (2017-2022) & (K Doses)
    Table 80. Asia Pacific Genetic Disorders Drug Sales by Region (2023-2028) & (K Doses)
    Table 81. Asia Pacific Genetic Disorders Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Genetic Disorders Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Genetic Disorders Drug Sales by Type (2017-2022) & (K Doses)
    Table 84. Latin America Genetic Disorders Drug Sales by Type (2023-2028) & (K Doses)
    Table 85. Latin America Genetic Disorders Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Genetic Disorders Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Genetic Disorders Drug Sales by Application (2017-2022) & (K Doses)
    Table 88. Latin America Genetic Disorders Drug Sales by Application (2023-2028) & (K Doses)
    Table 89. Latin America Genetic Disorders Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Genetic Disorders Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Genetic Disorders Drug Sales by Country (2017-2022) & (K Doses)
    Table 92. Latin America Genetic Disorders Drug Sales by Country (2023-2028) & (K Doses)
    Table 93. Latin America Genetic Disorders Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Genetic Disorders Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Genetic Disorders Drug Sales by Type (2017-2022) & (K Doses)
    Table 96. Middle East and Africa Genetic Disorders Drug Sales by Type (2023-2028) & (K Doses)
    Table 97. Middle East and Africa Genetic Disorders Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Genetic Disorders Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Genetic Disorders Drug Sales by Application (2017-2022) & (K Doses)
    Table 100. Middle East and Africa Genetic Disorders Drug Sales by Application (2023-2028) & (K Doses)
    Table 101. Middle East and Africa Genetic Disorders Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Genetic Disorders Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Genetic Disorders Drug Sales by Country (2017-2022) & (K Doses)
    Table 104. Middle East and Africa Genetic Disorders Drug Sales by Country (2023-2028) & (K Doses)
    Table 105. Middle East and Africa Genetic Disorders Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Genetic Disorders Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Sanofi Corporation Information
    Table 108. Sanofi Description and Major Businesses
    Table 109. Sanofi Genetic Disorders Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 110. Sanofi Genetic Disorders Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Sanofi Recent Developments
    Table 112. Vertex Corporation Information
    Table 113. Vertex Description and Major Businesses
    Table 114. Vertex Genetic Disorders Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 115. Vertex Genetic Disorders Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Vertex Recent Developments
    Table 117. Takeda Corporation Information
    Table 118. Takeda Description and Major Businesses
    Table 119. Takeda Genetic Disorders Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 120. Takeda Genetic Disorders Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Takeda Recent Developments
    Table 122. Amgen Corporation Information
    Table 123. Amgen Description and Major Businesses
    Table 124. Amgen Genetic Disorders Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 125. Amgen Genetic Disorders Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Amgen Recent Developments
    Table 127. GW Pharmaceuticals Corporation Information
    Table 128. GW Pharmaceuticals Description and Major Businesses
    Table 129. GW Pharmaceuticals Genetic Disorders Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 130. GW Pharmaceuticals Genetic Disorders Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. GW Pharmaceuticals Recent Developments
    Table 132. Pfizer Corporation Information
    Table 133. Pfizer Description and Major Businesses
    Table 134. Pfizer Genetic Disorders Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 135. Pfizer Genetic Disorders Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Pfizer Recent Developments
    Table 137. BioMarin Corporation Information
    Table 138. BioMarin Description and Major Businesses
    Table 139. BioMarin Genetic Disorders Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 140. BioMarin Genetic Disorders Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. BioMarin Recent Developments
    Table 142. Sarepta Corporation Information
    Table 143. Sarepta Description and Major Businesses
    Table 144. Sarepta Genetic Disorders Drug Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 145. Sarepta Genetic Disorders Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Sarepta Recent Developments
    Table 147. Key Raw Materials Lists
    Table 148. Raw Materials Key Suppliers Lists
    Table 149. Genetic Disorders Drug Distributors List
    Table 150. Genetic Disorders Drug Customers List
    Table 151. Genetic Disorders Drug Market Trends
    Table 152. Genetic Disorders Drug Market Drivers
    Table 153. Genetic Disorders Drug Market Challenges
    Table 154. Genetic Disorders Drug Market Restraints
    Table 155. Research Programs/Design for This Report
    Table 156. Key Data Information from Secondary Sources
    Table 157. Key Data Information from Primary Sources
List of Figures
    Figure 1. Genetic Disorders Drug Product Picture
    Figure 3. Global Genetic Disorders Drug Market Share by Type in 2021 & 2028
    Figure 3. Cystic Fibrosis (CF) Product Picture
    Figure 4. Duchenne Muscular Dystrophy (DMD) Product Picture
    Figure 5. Lysosomal Storage Disease (LSD) Product Picture
    Figure 6. Paroxysmal Nocturnal Hemoglobinuria (PNH) Product Picture
    Figure 7. Global Genetic Disorders Drug Market Share by Application in 2021 & 2028
    Figure 8. Clinic
    Figure 9. Hospital
    Figure 10. Genetic Disorders Drug Report Years Considered
    Figure 11. Global Genetic Disorders Drug Sales 2017-2028 (K Doses)
    Figure 12. Global Genetic Disorders Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Genetic Disorders Drug Revenue 2017-2028 (US$ Million)
    Figure 14. Global Genetic Disorders Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Genetic Disorders Drug Sales Market Share by Region (2017-2022)
    Figure 16. Global Genetic Disorders Drug Sales Market Share by Region (2023-2028)
    Figure 17. North America Genetic Disorders Drug Sales YoY (2017-2028) & (K Doses)
    Figure 18. North America Genetic Disorders Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Genetic Disorders Drug Sales YoY (2017-2028) & (K Doses)
    Figure 20. Europe Genetic Disorders Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Genetic Disorders Drug Sales YoY (2017-2028) & (K Doses)
    Figure 22. Asia-Pacific Genetic Disorders Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Genetic Disorders Drug Sales YoY (2017-2028) & (K Doses)
    Figure 24. Latin America Genetic Disorders Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Genetic Disorders Drug Sales YoY (2017-2028) & (K Doses)
    Figure 26. Middle East & Africa Genetic Disorders Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Genetic Disorders Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Genetic Disorders Drug in the World: Market Share by Genetic Disorders Drug Revenue in 2021
    Figure 29. Global Genetic Disorders Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Genetic Disorders Drug Sales Market Share by Type (2017-2028)
    Figure 31. Global Genetic Disorders Drug Revenue Market Share by Type (2017-2028)
    Figure 32. Global Genetic Disorders Drug Sales Market Share by Application (2017-2028)
    Figure 33. Global Genetic Disorders Drug Revenue Market Share by Application (2017-2028)
    Figure 34. North America Genetic Disorders Drug Sales Market Share by Type (2017-2028)
    Figure 35. North America Genetic Disorders Drug Revenue Market Share by Type (2017-2028)
    Figure 36. North America Genetic Disorders Drug Sales Market Share by Application (2017-2028)
    Figure 37. North America Genetic Disorders Drug Revenue Market Share by Application (2017-2028)
    Figure 38. North America Genetic Disorders Drug Sales Share by Country (2017-2028)
    Figure 39. North America Genetic Disorders Drug Revenue Share by Country (2017-2028)
    Figure 40. U.S. Genetic Disorders Drug Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Genetic Disorders Drug Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Genetic Disorders Drug Sales Market Share by Type (2017-2028)
    Figure 43. Europe Genetic Disorders Drug Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Genetic Disorders Drug Sales Market Share by Application (2017-2028)
    Figure 45. Europe Genetic Disorders Drug Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Genetic Disorders Drug Sales Share by Country (2017-2028)
    Figure 47. Europe Genetic Disorders Drug Revenue Share by Country (2017-2028)
    Figure 48. Germany Genetic Disorders Drug Revenue (2017-2028) & (US$ Million)
    Figure 49. France Genetic Disorders Drug Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Genetic Disorders Drug Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Genetic Disorders Drug Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Genetic Disorders Drug Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Genetic Disorders Drug Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Genetic Disorders Drug Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Genetic Disorders Drug Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Genetic Disorders Drug Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Genetic Disorders Drug Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Genetic Disorders Drug Revenue Share by Region (2017-2028)
    Figure 59. China Genetic Disorders Drug Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Genetic Disorders Drug Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Genetic Disorders Drug Revenue (2017-2028) & (US$ Million)
    Figure 62. India Genetic Disorders Drug Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Genetic Disorders Drug Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan Genetic Disorders Drug Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Genetic Disorders Drug Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Genetic Disorders Drug Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Genetic Disorders Drug Revenue (2017-2028) & (US$ Million)
    Figure 68. Philippines Genetic Disorders Drug Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Genetic Disorders Drug Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Genetic Disorders Drug Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Genetic Disorders Drug Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Genetic Disorders Drug Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Genetic Disorders Drug Sales Share by Country (2017-2028)
    Figure 74. Latin America Genetic Disorders Drug Revenue Share by Country (2017-2028)
    Figure 75. Mexico Genetic Disorders Drug Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Genetic Disorders Drug Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Genetic Disorders Drug Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Genetic Disorders Drug Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Genetic Disorders Drug Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Genetic Disorders Drug Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Genetic Disorders Drug Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Genetic Disorders Drug Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Genetic Disorders Drug Revenue Share by Country (2017-2028)
    Figure 84. Turkey Genetic Disorders Drug Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Genetic Disorders Drug Revenue (2017-2028) & (US$ Million)
    Figure 86. U.A.E Genetic Disorders Drug Revenue (2017-2028) & (US$ Million)
    Figure 87. Genetic Disorders Drug Value Chain
    Figure 88. Genetic Disorders Drug Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi
Vertex
Takeda
Amgen
GW Pharmaceuticals
Pfizer
BioMarin
Sarepta
Frequently Asked Questions
Genetic Disorders Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Genetic Disorders Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Genetic Disorders Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Marine Antennas

Marine Antennas market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More

Marine Speaker

Marine Speaker market is segmented by Type and by Application. Players, stakeholders, and other p ... Read More

Cloud Storage

Cloud Storage market is segmented by players, region (country), by Type and by Application. Playe ... Read More